Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/33509
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSalamonsen L.A.en
dc.contributor.authorMarsh M.M.en
dc.contributor.authorMalakooti N.en
dc.contributor.authorTaylor N.H.en
dc.contributor.authorFindlay J.K.en
dc.date.accessioned2021-05-14T11:21:28Zen
dc.date.available2021-05-14T11:21:28Zen
dc.date.copyright1997en
dc.date.created19971111en
dc.date.issued1997-11-11en
dc.identifier.citationHuman Reproduction. 12 (9) (pp 2036-2040), 1997. Date of Publication: 1997.en
dc.identifier.issn0268-1161en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/33509en
dc.description.abstractThe mechanisms underlying excessive menstrual bleeding or menorrhagia are not understood. In view of its potent vasoconstrictor and growth factor properties, endothelin has been proposed to have a potential paracrine role in the regulation of uterine blood flow and therefore could be a factor in menorrhagia. We compared the cellular localization of endothelin and its metabolizing enzyme, neutral endopeptidase, in endometrial biopsies from women with documented menorrhagia and in those with a normal menstrual cycle. Menorrhagia was documented by measurement of menstual blood loss, 146 +/- 141 ml (median +/- SD). Endothelin and neutral endopeptidase were localized by immunohistochemistry, and the staining intensity was graded. Their immunostaining patterns were found to differ in menorrhagia compared to the normal menstrual cycle. Endothelin was reduced in glandular epithelium in menorrhagia and did not vary cyclically, while neutral endopeptidase was increased in the glandular epithelium. In menorrhagia, stromal endothelin immunoreactivity was not different from the normal cycle and although neutral endopeptidase immunostaining in stroma was similar to the secretory phase of normal endometrium, cyclical variation was absent. The potential for increased metabolism of endothelin could be an explanation for the decreased endothelin immunostaining in the glandular epithelium.en
dc.languageEnglishen
dc.languageenen
dc.publisherOxford University Pressen
dc.relation.ispartofHuman Reproductionen
dc.titleEndothelin and neutral endopeptidase in the endometrium of women with menorrhagia.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/humrep/12.9.2036en
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid9363725 [http://www.ncbi.nlm.nih.gov/pubmed/?term=9363725]en
dc.identifier.source27462488en
dc.identifier.institution(Marsh, Malakooti, Findlay, Salamonsen) Prnc. Henry's Inst. of Med. Research, PO Box 5152, Clayton 3168, Australia (Taylor) Monash University, Department of Obstetrics, Monash Medical Centre, 246 Clayton Road, Clayton, Vic. 3168, Australiaen
dc.description.addressL.A. Salamonsen, Prince Henry's Inst Medical Research, PO Box 5152, Clayton, Vic. 3168, Australiaen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2018 Elsevier B.V., All rights reserved.en
dc.subect.keywordsEndometrium Endothelin-1 Intrauterine device Menorrhagia Neutral endopeptidaseen
item.grantfulltextnone-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
Appears in Collections:Articles
Show simple item record

Page view(s)

10
checked on Sep 6, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.